Why Expand HLA-DQ Representation in Single Antigen Bead Assays?

Expanded HLA-DQ representation in single antigen bead assays may provide laboratories with additional insight into antibody patterns and improve confidence in antibody interpretation workflows.

In this live webinar, members of the team behind LABScreen Single Antigen ExPlex will discuss the rationale for expanded DQ representation, review practical interpretation challenges, and demonstrate how HLA Fusion software tools can support real-world antibody analysis.

Attendees will gain practical insight into interpretation strategies, workflow considerations, and the potential impact of expanded antigen coverage on antibody assessment confidence.

Learning objectives:

Understand the rationale for expanded HLA-DQ representation in single antigen bead assays
Interpret HLA-DQ antibody patterns using practical case-based examples
Apply HLA Fusion software tools to antibody analysis workflows
Evaluate the operational and interpretive impact of expanded antigen coverage

Guest speakers

Dave Lowe

Senior Director, Research and Development, Transplant Diagnostics, Thermo Fisher Scientific

James Jones

Sr Customer Service Training Specialist – Antibodies, Transplant Diagnostics, Thermo Fisher Scientific

Moderator

Richard Battle, PhD, FRCPath

Senior Manager, Scientific Affairs, Transplant Diagnostics, Thermo Fisher Scientific

First name

Last name

Country/Region

⠀

I confirm that I would like to receive marketing and promotional emails about products and services from Thermo Fisher Scientific Inc. and its affiliates.
You may unsubscribe at any time by clicking on the unsubscribe link in any of the marketing communication you receive.
By submitting this form you agree to Thermo Fisher Scientific Inc. Terms of Use and Privacy Notice, including transfer of your personal data to countries outside your country of residence.

For Research Use Only. Not for use in diagnostic procedures. Availability of product in each country depends on local regulatory marketing authorization status.